Working… Menu
Trial record 1 of 1 for:    DaunoDouble | AML | Germany
Previous Study | Return to List | Next Study

Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML (DaunoDouble)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02140242
Recruitment Status : Recruiting
First Posted : May 16, 2014
Last Update Posted : August 6, 2020
Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC)
Masaryk University
Information provided by (Responsible Party):
Technische Universität Dresden

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : August 2021